New treatment approach targets a subset of common blood cancer that is more deadly in women than in men

In a finding that challenges decades of assumptions about blood cancer, an international research team has shown for the first time that a specific subtype of diffuse large B cell lymphoma (DLBCL), which is the most common blood cancer in adults, is dramatically more lethal in women than in men.